Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 9000189)

Published in Urology on January 01, 1997

Authors

J F Caubet1, T D Tosteson, E W Dong, E M Naylon, G W Whiting, M S Ernstoff, S D Ross

Author Affiliations

1: MetaWorks, Inc., Boston, Massachusetts 02210, USA.

Articles citing this

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Ann Oncol (2015) 2.99

Meta-analysis: neither quick nor easy. BMC Med Res Methodol (2002) 1.38

Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease. Urol Oncol (2009) 1.14

Blockade of testicular and adrenal androgens in prostate cancer treatment. Nat Rev Urol (2011) 1.06

Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review. J Clin Oncol (2007) 1.05

Evaluating the role of quality assessment of primary studies in systematic reviews of cancer practice guidelines. BMC Med Res Methodol (2005) 0.93

Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. Br J Cancer (2014) 0.92

Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int (2008) 0.92

Steroid hormone synthetic pathways in prostate cancer. Transl Androl Urol (2013) 0.89

Antiandrogens in prostate cancer. Invest New Drugs (1999) 0.86

Abiraterone in the treatment of metastatic castration-resistant prostate cancer. Cancer Manag Res (2014) 0.83

Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review. Curr Oncol (2006) 0.81

The evolution of hormonal therapy for prostatic carcinoma. Rev Urol (2001) 0.79

Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre. Asian J Androl (2010) 0.78

The course of metastatic prostate cancer under treatment. Springerplus (2014) 0.75

Androgen deprivation and other treatments for advanced prostate cancer. Rev Urol (2001) 0.75

Role of maximum androgen blockade in advanced prostate cancer. Indian J Urol (2009) 0.75

Articles by these authors

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12

The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis (1992) 3.01

Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med (1997) 2.99

The impact of spinal problems on the health status of patients: have we underestimated the effect? Spine (Phila Pa 1976) (2000) 2.51

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37

Rotating shift work, sleep, and accidents related to sleepiness in hospital nurses. Am J Public Health (1992) 2.24

Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20

The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med (1995) 2.20

Early childhood predictors of asthma. Am J Epidemiol (1990) 2.10

Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06

Cognitive effects of one season of head impacts in a cohort of collegiate contact sport athletes. Neurology (2012) 1.94

Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis (1993) 1.90

Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol (2001) 1.80

Clinical outcomes in reduction mammaplasty: a systematic review and meta-analysis of published studies. Mayo Clin Proc (2001) 1.74

A long-term study of mortality in men who have undergone vasectomy. N Engl J Med (1992) 1.70

Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol (2000) 1.69

Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.64

Cancer early-detection services in community health centers for the underserved. A randomized controlled trial. Arch Fam Med (1998) 1.63

Adverse drug reactions in hospitalized patients: A critique of a meta-analysis. MedGenMed (2000) 1.59

Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis (1994) 1.59

Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst (1990) 1.51

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest (1992) 1.45

Spinal cord protection during aortic cross-clamping using retrograde venous perfusion. Ann Thorac Surg (1999) 1.42

Retrograde perfusion with a sodium channel antagonist provides ischemic spinal cord protection. Ann Thorac Surg (2000) 1.41

Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis (1990) 1.41

Diagnosis and treatment of Parkinson's disease: a systematic review of the literature. Evid Rep Technol Assess (Summ) (2003) 1.39

Effects of asthma on pulmonary function in children. A longitudinal population-based study. Am Rev Respir Dis (1992) 1.33

Cryptogenic epilepsy: an infectious etiology? Epilepsia (2001) 1.29

In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23

Interferons in the treatment of human cancer. J Clin Oncol (1984) 1.22

K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev (1998) 1.16

Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst (1995) 1.14

Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health (2001) 1.13

Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis (1989) 1.12

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy (2006) 1.11

Lumbar discectomy outcomes vary by herniation level in the Spine Patient Outcomes Research Trial. J Bone Joint Surg Am (2008) 1.09

The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation (1995) 1.08

Personal exposures to respirable particulates and implications for air pollution epidemiology. Environ Sci Technol (1985) 1.07

Periodic health examinations and the provision of cancer prevention services. Arch Fam Med (1997) 1.06

Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann Thorac Surg (1999) 1.03

On methods of expressing dissolution rate data. J Pharm Pharmacol (1978) 1.00

Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers. Ann Intern Med (1985) 0.98

Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann Surg (2000) 0.96

A community-based randomized trial encouraging sun protection for children. Pediatrics (1998) 0.95

Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. J Immunol Methods (2001) 0.94

Normal human synovial fluid: osmolality and exercise-induced changes. J Bone Joint Surg Am (1985) 0.94

A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res (1985) 0.94

Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: A meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide. Prostate Cancer Prostatic Dis (1999) 0.94

A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters. J Urol (2000) 0.94

An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol (1992) 0.93

Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanoma. J Immunother Emphasis Tumor Immunol (1993) 0.93

Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol (1991) 0.92

Persistent increase in children's sun protection in a randomized controlled community trial. Prev Med (2000) 0.92

Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther (1999) 0.91

Durability of improved physician early detection of cancer after conclusion of intervention support. Cancer Epidemiol Biomarkers Prev (1994) 0.91

Prefabricated functional braces for the treatment of fractures of the tibial diaphysis. J Bone Joint Surg Am (1984) 0.90

Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma. Cancer Res (1998) 0.89

Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res (1995) 0.88

Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018). J Clin Oncol (1987) 0.87

Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial. Cancer Epidemiol Biomarkers Prev (2000) 0.86

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder. Cancer (1990) 0.86

Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol (2001) 0.86

The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study. Semin Urol (1993) 0.86

The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study. Ann Epidemiol (1996) 0.86

Sonographic characteristics of epidermoid cyst of testicle. Urology (1990) 0.85

Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital. Arch Dermatol (1987) 0.85

Role of interferons in the therapy of melanoma. J Invest Dermatol (1990) 0.83

Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplant (2007) 0.83

Dysplastic nevi in association with multiple primary melanoma. Cancer Res (1988) 0.83

Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: results in 36 patients. Eur J Cancer (1995) 0.83

Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. Br J Cancer (1991) 0.82

Lagrangian coherent structures are associated with fluctuations in airborne microbial populations. Chaos (2011) 0.82

T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res (1997) 0.82

Racial differences in pancreatic cancer: comparison of survival and histologic types of pancreatic carcinoma in Asians, blacks, and whites in the United States. Pancreas (2000) 0.82

Safety of nifedipine in angina pectoris: a meta-analysis. Hypertension (1999) 0.82

A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma. Epidemiology (1991) 0.81

Preparation of viable tumour cell vaccine from human solid tumours: relationship between tumour mass and cell yield. The Tissue Bank, Pittsburgh Cancer Institute. Melanoma Res (1993) 0.81

Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis. Clin Ther (1997) 0.81

DNA analysis of multiple synchronous renal cell carcinomas. Cancer (1990) 0.81

Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu. J Immunol Methods (2001) 0.80

Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum. Toxicol Appl Pharmacol (1994) 0.80

Clinical and roentgenographic results of decompression for lumbar spinal stenosis. J Spinal Disord (1994) 0.80

Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis (1995) 0.79

Internal compression arthrodesis of the ankle. Clin Orthop Relat Res (1985) 0.79

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu. J Immunother (2001) 0.79

Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. Am J Med (1984) 0.79

In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma. J Clin Oncol (1990) 0.78

Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group study. J Urol (1995) 0.78

Fluorouracil, interferon-alpha, and colon cancer: rational pursuit of synergism between antimetabolites and biologicals. J Clin Oncol (1989) 0.78